Real-world screening for diabetes in early pregnancy: Improved screening uptake using universal glycated haemoglobin
| Autor: | Emma Griffiths, Sally Singleton, Julia V. Marley, Erica Spry, Andrew B. Kirke, Emma Jamieson, Carly Roxburgh, Cynthia Porter, Kylie Sterry, David Atkinson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Blood Glucose
medicine.medical_specialty endocrine system diseases Screening test Endocrinology Diabetes and Metabolism Primary health care Early pregnancy factor Pregnancy Diabetes mellitus Internal Medicine medicine Humans Mass Screening Oral glucose tolerance Glycated haemoglobin Glycated Hemoglobin Nutrition and Dietetics biology business.industry Obstetrics Australia nutritional and metabolic diseases Glucose Tolerance Test medicine.disease Diabetes Gestational biology.protein Gestation Female Family Practice business |
| Zdroj: | Primary Care Diabetes. 15:995-1001 |
| ISSN: | 1751-9918 |
| Popis: | AIMS To improve perinatal outcomes, screening for hyperglycaemia using 75 g oral glucose tolerance test (OGTT) is recommended for all pregnant women at 24-28 weeks gestation (routine), and earlier if high-risk. Screening coverage for remote and Aboriginal Australian women is less than ideal. This study examined OGTT completion (early and routine) by women from rural and remote Western Australia compared with early glycated haemoglobin (HbA1c). METHODS In 2015-2018, 27 primary health care sites recruited 600 (233 Aboriginal) women aged ≥16-years, without pre-existing diabetes, who delivered >30-weeks gestation. All women presenting |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect